U.S. Online Retail and Ecommerce Stock News

Investors may be wondering whether Wingstop at around US$134.88 is starting to look interesting again, or if the stock’s valuation still feels out of step with its fundamentals. The share price has seen sharp moves recently, with a 17.8% decline over the last 7 days, an 18.8% decline over the last 30 days, and a 47.5% decline year to date. This will change how some investors think about both upside potential and risk. Recent coverage has focused on Wingstop’s position in the consumer...

If you are asking whether Sea at US$88.64 looks like an opportunity or a value trap, it helps to break the story into what the stock has done and what the numbers say about its worth. Sea's recent share price performance has been mixed, with a 4.4% return over the last week and 8.9% over the last month, set against a 32.6% decline year to date and a 39.2% decline over the past year. These moves come as investors continue to reassess high growth, cash intensive business models and weigh them...

Angi earnings shift draws investor focus Angi (ANGI) is in the spotlight after reporting first quarter 2026 results that showed sales of US$238.15 million, lower than the prior year, and a move from net income to a net loss. See our latest analysis for Angi. The earnings release and move to a quarterly net loss have coincided with a sharp reset in sentiment. Angi’s share price is at US$5.24 after a 90 day share price return of negative 55.78% and a 1 year total shareholder return of negative...

If you are wondering whether Ubiquiti at around US$926.69 is priced for perfection or still offers value, this article walks through what the current market price might be indicating. The stock has been volatile recently, with an 8.4% decline over the past week, a 10.7% return over 30 days, 63.6% year to date, 163.8% over 1 year, 435.7% over 3 years and 261.7% over 5 years. Recent attention on Ubiquiti has focused on its long term share price performance and what this means for current...

ACM Research, Inc. has reported its first-quarter 2026 results, with sales rising to US$231.26 million from US$172.35 million a year earlier, while net income eased to US$17.31 million and diluted earnings per share from continuing operations slipped to US$0.24. The company’s revenue came in ahead of pre-earnings expectations, but profitability weakened as margins tightened, highlighting the trade-off between rapid top-line expansion and earnings pressure. Next, we’ll examine how strong...

Recent performance snapshot Aura Minerals (AUGO) has moved sharply in recent months, with the stock down 9.6% over the past day and 8.7% over the past month, while showing a 22.9% gain in the past 3 months. See our latest analysis for Aura Minerals. Despite the recent 1-day and 1-month share price declines, Aura Minerals’ 62.1% year to date share price return and very large 1-year total shareholder return suggest that momentum has been strong rather than fading. If this kind of move in a gold...

Why Azenta’s latest quarter is drawing attention Azenta (AZTA) has come under pressure after its second quarter report, which combined a US$149,083,000 goodwill and intangible asset impairment with a wider net loss, prompting investors to reassess the stock. See our latest analysis for Azenta. The earnings report and US$149.1m impairment have clearly shifted sentiment, with the 7 day share price return of negative 24.42% feeding into a year to date share price return of negative 44.38% and a...

Papa John's International (PZZA) opened Q1 2026 with total revenue of US$478.6 million and basic EPS of US$0.22, alongside net income of US$7.3 million as investors weighed the latest set of numbers against a share price around US$32.85. Over recent quarters, revenue has moved from US$530.8 million in Q4 2024 to US$518.3 million in Q1 2025 and US$529.2 million in Q2 2025, while basic EPS tracked from US$0.45 in Q4 2024 through US$0.28 in Q2 2025 and US$0.14 in Q3 2025. This sets the backdrop...

Wondering if JBT Marel at US$138.02 is offering good value right now, or if the recent buzz has already been priced in. The stock has recorded a 16.9% return over the past 7 days and 10.1% over the last 30 days, while the 1 year return sits at 23.5% and the year to date return is an 8.3% decline. Recent coverage has focused on JBT Marel's progress as a combined business following the merger of JBT and Marel, along with investor attention on how the integration could affect margins and...

Why Ingersoll Rand (IR) is on investors’ radar Ingersoll Rand (IR) has drawn investor attention after a period of mixed share performance, with the stock showing negative returns over the past week, month and past 3 months despite positive multi year total returns. See our latest analysis for Ingersoll Rand. At a share price of US$77.50, Ingersoll Rand’s short term share price return has been weak, with a 21.32% 3 month decline. However, the 3 year total shareholder return of 34.14% reflects...

Why CG Oncology’s latest earnings matter for shareholders CG Oncology (CGON) reported first quarter revenue of US$1.08 million and a net loss of US$60.2 million, giving investors fresh numbers to reassess the stock’s risk and potential reward profile. See our latest analysis for CG Oncology. CG Oncology’s share price has moved to US$69.18, with a 1-day share price return of 1.72% and a 7-day return of 3.66%. The 90-day share price return of 37.37% and year-to-date share price return of 65.54%...

Why Teekay Tankers (TNK) is drawing fresh attention Teekay Tankers (TNK) is back on many watchlists after fourth quarter earnings and revenue came in ahead of analyst forecasts, followed by supportive analyst commentary that reinforced earlier positive ratings. See our latest analysis for Teekay Tankers. That earnings beat and the reaffirmed positive ratings have arrived alongside strong momentum, with a 21.77% 90 day share price return and a very large 5 year total shareholder return of...

In early May 2026, Harley-Davidson reported first-quarter net income of about US$24.77 million, sharply lower than a year earlier, as tariffs and higher costs compressed margins even while revenue of roughly US$1.17 billion exceeded analyst expectations and retail motorcycle sales rose, especially in North America. At the same time, management launched its "Back to the Bricks" turnaround plan, aiming to boost profitability through more affordable, rider-focused models, tighter dealer...

If you are wondering whether Alcoa’s current share price gives you value for your money, the key question is how that price compares with what the business might reasonably be worth. The stock closed at US$62.64, with a 1.8% decline over 7 days and a 14.1% decline over 30 days, set against a 10.8% gain year to date and a 146.3% return over 1 year that may catch your attention. Recent coverage has focused on Alcoa’s position within the broader materials sector and how investors are reacting...

T-Mobile US (NasdaqGS:TMUS) entered two major joint ventures to acquire and combine several regional fiber companies, expanding its national fiber footprint. The company introduced SuperBroadband for business customers, integrating Starlink satellite connectivity with its 5G offering. T-Mobile broadened its emergency preparedness program with international satellite-based coverage, upgraded fleet capabilities, and AI-supported network resilience tools. T-Mobile US, long known for its mobile...

In early May 2026, Scorpio Tankers Inc. reported a sharp year-on-year jump in first-quarter net income to US$216.26 million, alongside new US$375 million 1.75% convertible senior notes due 2031, a US$0.45 quarterly dividend, a US$500 million buyback authorization, and a new US$50 million credit facility for two LR2 tankers. This combination of stronger profitability, fresh financing, and ongoing fleet renewal signals a company focusing on balance sheet strength while continuing to return...

AngloGold Ashanti plc has reported first-quarter 2026 net income of US$1.28 billion, with basic earnings per share from continuing operations rising to US$2.52, driven by strong gold prices, robust operations, record free cash flow of US$1.20 billion, a higher interim dividend of US$1.16 per share, and a proposed US$2.00 billion share repurchase programme. Alongside these financial results, the company is advancing growth through projects like the Arthur Gold Project in Nevada, which now...

In early May 2026, Lineage, Inc. reported first-quarter 2026 results showing revenue of US$1.30 billion, a net loss of US$46 million, and funds from operations of US$0.78 per share that exceeded analyst estimates despite industry headwinds. Management reaffirmed full-year 2026 guidance, highlighted an ongoing plan to remove more than US$50 million in administrative costs by 2027, and progressed a portfolio review aimed at strengthening financial flexibility in an oversupplied cold storage...

Recent move in Cboe Global Markets (CBOE) Cboe Global Markets (CBOE) drew fresh attention after its stock closed at $339.98, with recent returns of 13.3% over the past week and 24.4% over the past 3 months prompting closer review. See our latest analysis for Cboe Global Markets. Despite a 1.7% pullback in the latest session, Cboe Global Markets has strong momentum, with a 37.0% year to date share price return and a 50.7% 1 year total shareholder return. If the recent gains in Cboe have you...

Unsurprisingly, Ambitions Enterprise Management Co. L.L.C's ( NASDAQ:AHMA ) stock price was strong on the back of its...

A week ago, Bowhead Specialty Holdings Inc. ( NYSE:BOW ) came out with a strong set of first-quarter numbers that could...

Bitdeer Technologies Group's ( NASDAQ:BTDR ) stock was strong after they recently reported robust earnings. However...

For investors wondering whether Bristol-Myers Squibb at around US$56.25 is offering value or risk at this point, this article breaks down what the current price might be indicating about the stock. The share price has had a mixed run, with a 7.2% loss over the last week and a 2.5% loss over the last month, but it is still up 5.2% year to date and 26.0% over the past year. Recent headlines around Bristol-Myers Squibb have focused on its position within the broader pharmaceuticals space and on...

Iovance Biotherapeutics (IOVA) opened Q1 2026 with revenue of US$71.4 million and a basic EPS loss of US$0.19, alongside net income excluding extra items at a loss of US$79.0 million. Over recent quarters, the company has seen revenue move from US$49.3 million in Q1 2025 to US$71.4 million in Q1 2026. Quarterly basic EPS losses ranged between US$0.18 and US$0.36 across that period, illustrating that top line scale is increasing while spending remains high and margins stay under pressure. See...